Drug Reduces Fatty Liver Disease Symptoms in Trial | Newsmax.com

The drug, denifanstat, was administered to 168 Metabolic dysfunction-associated steatohepatitis (MASH, formerly known as nonalcoholic steatohepatitis …

scroll to top